Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010
Chris Mason, Elisa Manzotti
Regenerative Medicine (2010) Vol. 5, Iss. 3, pp. 307-313
Closed Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Additive manufacturing of tissues and organs
Ferry P.W. Melchels, Marco Domingos, Travis J. Klein, et al.
Progress in Polymer Science (2011) Vol. 37, Iss. 8, pp. 1079-1104
Open Access | Times Cited: 1126
Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology
Michael Kalos, Carl H. June
Immunity (2013) Vol. 39, Iss. 1, pp. 49-60
Open Access | Times Cited: 462
The Translation of Cell-Based Therapies: Clinical Landscape and Manufacturing Challenges
Thomas R.J. Heathman, Alvin W. Nienow, Mark McCall, et al.
Regenerative Medicine (2015) Vol. 10, Iss. 1, pp. 49-64
Open Access | Times Cited: 269
Designing Regenerative Biomaterial Therapies for the Clinic
E. Thomas Pashuck, Molly M. Stevens
Science Translational Medicine (2012) Vol. 4, Iss. 160
Closed Access | Times Cited: 228
Cell sheet engineering for regenerative medicine: Current challenges and strategies
Toshiyuki Owaki, Tatsuya Shimizu, Masayuki Yamato, et al.
Biotechnology Journal (2014) Vol. 9, Iss. 7, pp. 904-914
Closed Access | Times Cited: 174
Cell Therapy Industry: Billion Dollar Global Business with Unlimited Potential
Chris Mason, David Brindley, Emily J Culme-Seymour, et al.
Regenerative Medicine (2011) Vol. 6, Iss. 3, pp. 265-272
Closed Access | Times Cited: 147
Progress in the Tissue Engineering and Stem Cell Industry “Are we there yet?”
Ana Jaklenec, Andrea Stamp, Elizabeth Deweerd, et al.
Tissue Engineering Part B Reviews (2012) Vol. 18, Iss. 3, pp. 155-166
Closed Access | Times Cited: 124
Novel Collagen/Gelatin Scaffold with Sustained Release of Basic Fibroblast Growth Factor: Clinical Trial for Chronic Skin Ulcers
Naoki Morimoto, Kenichi Yoshimura, Miyuki Niimi, et al.
Tissue Engineering Part A (2013) Vol. 19, Iss. 17-18, pp. 1931-1940
Open Access | Times Cited: 89
3D Biomaterial Microarrays for Regenerative Medicine: Current State‐of‐the‐Art, Emerging Directions and Future Trends
Akhilesh K. Gaharwar, Ayyoob Arpanaei, Thomas L. Andresen, et al.
Advanced Materials (2015) Vol. 28, Iss. 4, pp. 771-781
Open Access | Times Cited: 89
Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation
Jane Bryant, Kelan A. Hlavaty, Xiaomin Zhang, et al.
Biomaterials (2014) Vol. 35, Iss. 31, pp. 8887-8894
Open Access | Times Cited: 80
Natural zwitterionic betaine enables cells to survive ultrarapid cryopreservation
Jing Yang, Nana Cai, Hongwen Zhai, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 76
Autologous adipose tissue-derived stromal vascular fraction cells application in patients with osteoarthritis
Jaroslav Michálek, R Moster, L Lukác, et al.
Cell Transplantation (2015)
Closed Access | Times Cited: 75
An Overview of the Tissue Engineering Market in the United States from 2011 to 2018
Yu Seon Kim, Mollie M. Smoak, Anthony J. Melchiorri, et al.
Tissue Engineering Part A (2018) Vol. 25, Iss. 1-2, pp. 1-8
Open Access | Times Cited: 74
A Decade of Cell Therapy Clinical Trials (2000–2010)
Emily J Culme-Seymour, Natasha L. Davie, David Brindley, et al.
Regenerative Medicine (2012) Vol. 7, Iss. 4, pp. 455-462
Closed Access | Times Cited: 66
On the Genealogy of Tissue Engineering and Regenerative Medicine
Himanshu Kaul, Yiannis Ventikos
Tissue Engineering Part B Reviews (2014) Vol. 21, Iss. 2, pp. 203-217
Open Access | Times Cited: 57
Preclinical imaging methods for assessing the safety and efficacy of regenerative medicine therapies
Lauren Scarfe, Nathalie Brillant, J. Dinesh Kumar, et al.
npj Regenerative Medicine (2017) Vol. 2, Iss. 1
Open Access | Times Cited: 57
DMSO‐ and Serum‐Free Cryopreservation of Wharton's Jelly Tissue Isolated From Human Umbilical Cord
Sharath Belame Shivakumar, Dinesh Bharti, Raghavendra Baregundi Subbarao, et al.
Journal of Cellular Biochemistry (2016) Vol. 117, Iss. 10, pp. 2397-2412
Open Access | Times Cited: 54
Human-Based Biological and Biomimetic Autologous Therapies for Musculoskeletal Tissue Regeneration
Sabino Padilla, Mikel Sánchez, Gorka Orive, et al.
Trends in biotechnology (2016) Vol. 35, Iss. 3, pp. 192-202
Closed Access | Times Cited: 54
Regenerative medicine: the emergence of an industry
Robert M. Nerem
Journal of The Royal Society Interface (2010) Vol. 7, Iss. suppl_6
Open Access | Times Cited: 65
Natural ECM as Biomaterial for Scaffold Based Cardiac Regeneration Using Adult Bone Marrow Derived Stem Cells
P. Sreejit, Rama Shanker Verma
Stem Cell Reviews and Reports (2013) Vol. 9, Iss. 2, pp. 158-171
Closed Access | Times Cited: 54
Skeletal Tissue Regeneration: Current Approaches, Challenges, and Novel Reconstructive Strategies for an Aging Population
James O. Smith, Alexander Aarvold, Edward Tayton, et al.
Tissue Engineering Part B Reviews (2011) Vol. 17, Iss. 5, pp. 307-320
Closed Access | Times Cited: 51
Regenerative Medicine Primer
André Terzic, Timothy J. Nelson
Mayo Clinic Proceedings (2013) Vol. 88, Iss. 7, pp. 766-775
Closed Access | Times Cited: 49
The Assessment of Cryopreservation Conditions for Human Umbilical Cord Stroma-Derived Mesenchymal Stem Cells towards a Potential Use for Stem Cell Banking
Deniz Balcı, Alp Can
Current Stem Cell Research & Therapy (2013) Vol. 8, Iss. 1, pp. 60-72
Closed Access | Times Cited: 47
Bringing Regenerative Medicines to the Clinic: The Future for Regulation and Reimbursement
Tania Bubela, Christopher McCabe, Peter Archibald, et al.
Regenerative Medicine (2015) Vol. 10, Iss. 7, pp. 897-911
Open Access | Times Cited: 45
Cell based advanced therapeutic medicinal products for bone repair: Keep it simple?
Jeroen Leijten, Yoke Chin Chai, Ioannis Papantoniou, et al.
Advanced Drug Delivery Reviews (2014) Vol. 84, pp. 30-44
Closed Access | Times Cited: 44
Page 1 - Next Page

Scroll to top